Patent ID: 11911362
Assignee: TULEX PHARMACEUTICALS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 10:
11. A direct dosing device consisting of a liquid pharmaceutical composition, wherein the liquid pharmaceutical composition comprises:
(a) polyethylene glycol in an amount of about 40% w/v to about 70% w/v;
(b) one or more preservatives selected from parabens, benzyl alcohol, benzoic acid, sorbic acid, sodium benzoate, and ascorbic acid;
(c) glycerin in an amount of about 60% to about 70% w/v;
(d) topiramate, or a pharmaceutically acceptable addition salt thereof, in an amount of about 25 mg/ml;
(e) one or more sweeteners; and
(f) optionally, a flavor component comprising one or more flavor compounds;
wherein the liquid pharmaceutical composition is ready-to-use without dilution and configured to be administered directly to a subject in need thereof without adding water, aqueous acid or base; and
wherein the liquid pharmaceutical composition is a liquid for oral administration.